Medical isotope developer IsoRay of Richland, WA, reported that its low-dose rate (LDR) cesium-131 brachytherapy seed for the treatment of prostate cancer is now available at Durham Regional Hospital in Durham, NC.
Durham Regional Hospital is a 369-bed acute care facility, and is affiliated with the Duke University Medical Center.
By AuntMinnie.com staff writers
November 29, 2005
Related Reading
IsoRay opens new production facility, November 3, 2005
IsoRay raises $10 million, June 28, 2005
IsoRay implants first cesium-131 seed, October 27, 2004
IsoRay inks deal with PNNL and U.S. DOE, May 11, 2004
Copyright © 2005 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
